MA28334A1 - Compositions pharmaceutiques antivirales - Google Patents

Compositions pharmaceutiques antivirales

Info

Publication number
MA28334A1
MA28334A1 MA29172A MA29172A MA28334A1 MA 28334 A1 MA28334 A1 MA 28334A1 MA 29172 A MA29172 A MA 29172A MA 29172 A MA29172 A MA 29172A MA 28334 A1 MA28334 A1 MA 28334A1
Authority
MA
Morocco
Prior art keywords
antiviral compositions
pharmaceutical antiviral
pharmaceutical
present
compositions
Prior art date
Application number
MA29172A
Other languages
English (en)
Inventor
Andrew Xian Chen
Original Assignee
Sd Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sd Pharmaceuticals Inc filed Critical Sd Pharmaceuticals Inc
Publication of MA28334A1 publication Critical patent/MA28334A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne un procédé pour préparer du 5-chlore-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phényl]-1,3-oxazolidin-5-yl}-méthyl)-2-thiophène carboxamide à partir de 2-[(2S)-2-oxiranylméthyl]-1H-isoindol-1,3(2H)-dione, de 4-(4-aminophényl)-3-morpholinone et de chlorure de 5-chlorthiophène-2-carbonyl.
MA29172A 2003-12-10 2006-07-07 Compositions pharmaceutiques antivirales MA28334A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52884303P 2003-12-10 2003-12-10
US11/003,302 US7968122B2 (en) 2003-12-10 2004-12-03 Anti-viral pharmaceutical compositions

Publications (1)

Publication Number Publication Date
MA28334A1 true MA28334A1 (fr) 2006-12-01

Family

ID=34840339

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29172A MA28334A1 (fr) 2003-12-10 2006-07-07 Compositions pharmaceutiques antivirales

Country Status (16)

Country Link
US (2) US7968122B2 (fr)
EP (1) EP1706122B1 (fr)
JP (1) JP2007513959A (fr)
KR (1) KR20060118573A (fr)
AT (1) ATE415166T1 (fr)
AU (1) AU2004315262A1 (fr)
BR (1) BRPI0417559A (fr)
CA (1) CA2549083A1 (fr)
DE (1) DE602004018032D1 (fr)
DK (1) DK1706122T3 (fr)
EA (1) EA200601124A1 (fr)
IL (1) IL176161A0 (fr)
MA (1) MA28334A1 (fr)
MX (1) MXPA06006650A (fr)
NO (1) NO20063147L (fr)
WO (1) WO2005074947A2 (fr)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006062857A2 (fr) * 2004-12-09 2006-06-15 The Dial Corporation Compositions presentant une efficacite antibacterienne et antivirale elevee
US20090012174A1 (en) * 2004-12-09 2009-01-08 The Dial Corporation Compositions Having a High Antiviral and Antibacterial Efficacy
WO2006062897A2 (fr) * 2004-12-09 2006-06-15 The Dial Corporation Compositions presentant une efficacite antivirale et antibacterienne elevee
WO2006062846A2 (fr) * 2004-12-09 2006-06-15 The Dial Corporation Compositions presentant une efficacite antivirale et antibacterienne elevee
MX2007006860A (es) * 2004-12-09 2008-02-15 Dial Corp Composiciones que tienen alta eficacia antiviral y antibacterial.
US8088400B2 (en) * 2005-08-22 2012-01-03 Quick-Med Technologies, Inc. Disinfectant with quarternary ammonium polymer and copolymers
US20080000473A1 (en) * 2005-12-29 2008-01-03 Hugo Stephenson pH-Based Methods and Devices for Preventing Hemagglutinin Cell Membrane Fusion
DE602006005612D1 (de) * 2006-04-04 2009-04-23 Marinomed Biotechnologie Gmbh Zellulosesulfat zur Behandlung von Rhinovirus-Infektionen
EP2007401A2 (fr) * 2006-04-04 2008-12-31 Marinomed Biotechnologie GmbH Polymère anti-inflammatoire
US20090238883A1 (en) * 2006-04-28 2009-09-24 Kren Betsy T Liver-specific nanocapsules and methods of using
EP2040544A2 (fr) * 2006-05-26 2009-04-01 The Dial Corporation Procédé d'inhibition de la transmission de virus
RU2008152402A (ru) * 2006-05-30 2010-07-10 Дзе Дайл Корпорейшн (Us) Композиции, обладающие сильным противовирусным действием
EP2034831A2 (fr) * 2006-05-31 2009-03-18 The Dial Corporation Préparations antimicrobiennes contenant de l'alcool d'efficacité améliorée
WO2008036134A2 (fr) 2006-06-02 2008-03-27 The Dial Corporation Méthode destinée à inhiber la transmission du virus influenza
WO2007145886A2 (fr) * 2006-06-05 2007-12-21 The Dial Corporation Procédés et articles ayant une efficacité antivirale et antibacterienne élevée
DE102006033167A1 (de) * 2006-07-10 2008-01-24 Gelita Ag Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung eines vernetzenden medizinischen Klebers
TWI394564B (zh) * 2006-09-21 2013-05-01 Alcon Res Ltd 自行保存型水性藥學組成物
WO2008042891A2 (fr) * 2006-10-02 2008-04-10 Oregan Biomedical Engineering Institute, Inc. Dispositifs ophtalmiques en chitosane et procédés
WO2008157514A2 (fr) * 2007-06-14 2008-12-24 Genesegues, Inc. Polymères biocompatibles traités par ion métallique utiles pour des nanoparticules
JP5558458B2 (ja) * 2008-03-20 2014-07-23 タノメド・アクチボラゲット 普通感冒の治療用の医薬の製造における物質の使用
KR101602516B1 (ko) * 2008-07-07 2016-03-10 트루텍 코프. 정전기를 띤 다중 작용 비강 적용물, 제품 및 방법
JP2012526857A (ja) * 2009-05-16 2012-11-01 トルテック コーポレーション 静電的に帯電した多作用性経鼻適用、製品及び方法
JPWO2011142484A1 (ja) * 2010-05-14 2013-07-22 株式会社日本触媒 ポリアルキレンイミンを含むウイルス感染症治療薬
EP2730621B1 (fr) * 2011-07-06 2016-09-28 NBC Meshtec, Inc. Élément de résine antiviral
GB2521488A (en) 2011-10-31 2015-06-24 Premiere Polish Company Ltd Personal care composition and a device for dispensing the same
EP2846773A4 (fr) 2012-05-10 2015-12-30 Painreform Ltd Préparations de dépôt d'un anesthésiant local et procédés de préparation associés
PL225045B1 (pl) * 2012-05-18 2017-02-28 Univ Jagiellonski Zastosowanie polimeru chitozanowego do wytwarzania leków do leczenia i profilaktyki infekcji wywołanych przez koronawirusy
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US20150018760A1 (en) * 2013-07-11 2015-01-15 Kathryn Morton HARDIN Nasal irrigation solution preparation system and method of preparation
US9192692B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan stenting paste
US9192574B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan paste wound dressing
WO2015072125A1 (fr) * 2013-11-14 2015-05-21 日本曹達株式会社 Composition anti-parvovirus
NO342617B1 (no) * 2014-06-18 2018-06-18 Meda Otc Ab Oral formulering omfattende et antibakterielt middel for å forebygge og/eller behandle halitose, dårlig ånde, munntørrhet eller sår hals
CN111700877A (zh) 2014-09-03 2020-09-25 吉倪塞思公司 治疗性纳米粒子和相关的组合物、方法和系统
AR100459A1 (es) * 2015-05-15 2016-10-05 Química Luar S R L Una composición farmacéutica antiviral de uso tópico
JP6570316B2 (ja) * 2015-05-25 2019-09-04 ロート製薬株式会社 爪用組成物
US20180200397A1 (en) * 2015-07-27 2018-07-19 Kimberty-Clark Worldwide, Inc. Disinfectant Composition with Rapid Antiviral Efficacy
US10293012B2 (en) 2017-05-04 2019-05-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods of using extracts of melissa officinalis against filoviruses
US11458203B2 (en) 2017-05-08 2022-10-04 Arizona Board Of Regents On Behalf Of Arizona State University Pharmaceutical compositions comprising caffeic acid chelates
US20210260107A1 (en) * 2018-06-25 2021-08-26 Triumph Pharmaceuticals Inc. Methods Of Inhibiting Microbial Infections Using Zinc-Containing Compositions
US11369578B2 (en) * 2018-11-15 2022-06-28 Bluewillow Biologics, Inc. Persistent topical antimicrobial compositions and methods of using the same
CN114681472B (zh) * 2019-03-13 2023-06-30 中国人民解放军军事科学院军事医学研究院 氨基葡萄糖及其衍生物作为抗病毒药物的应用
EP3888629A1 (fr) * 2020-03-31 2021-10-06 Dr. Kurt Wolff GmbH & Co. KG Composition pour le traitement ou la prévention d'une infection par un virus
WO2021211660A1 (fr) * 2020-04-14 2021-10-21 Vector Vitale Ip Llc Procédé de prévention ou de traitement d'infections virales
WO2021209493A2 (fr) * 2020-04-15 2021-10-21 Solyplus Gmbh Moyens et procédés de prévention et de traitement d'infections
CA3171226A1 (fr) * 2020-04-15 2021-10-21 Andreas Voigt Moyens et procedes de prevention et de traitement d'infections
US12186335B2 (en) 2020-04-23 2025-01-07 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting enveloped viruses using high molecular weight hydrophobically modified alkali swellable emulsion polymers and surfactant
US11690869B2 (en) * 2020-04-23 2023-07-04 Johnson & Johnson Consumer Inc. Methods of inhibiting enveloped viruses using low molecular weight hydrophobically modified polymers
US20210330698A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting enveloped viruses using low molecular weight hydrophobically modified polymers
KR102651711B1 (ko) * 2020-04-27 2024-03-27 조석형 항균 및 항바이러스제, 이의 제조방법 및 이로부터 제조된 보조사료
CN115734808A (zh) * 2020-06-30 2023-03-03 联合利华知识产权控股有限公司 消毒组合物
WO2022043678A1 (fr) * 2020-08-24 2022-03-03 Nanomerics Limited Inhibiteurs viraux
ES3024971T3 (en) * 2020-09-24 2025-06-05 Dr Kurt Wolff Gmbh & Co Kg Hydroxyapatite composition for treatment and/or prevention of a virus infection
WO2022135767A1 (fr) * 2020-12-22 2022-06-30 Solyplus Gmbh Moyens et méthodes de prévention, de traitement et de détection d'infections
JP2022124689A (ja) * 2021-02-16 2022-08-26 住友ベークライト株式会社 多層フィルム及び包装体
WO2022185326A1 (fr) * 2021-03-03 2022-09-09 Amitava Mazumder Compositions antivirales, anti-sars-cov-2, anti-h1n3, antibactériennes et antimicrobiennes et procédés de préparation correspondants
JP7664607B2 (ja) * 2021-03-31 2025-04-18 独立行政法人国立高等専門学校機構 ウイルス不活化構造
EP4324467A4 (fr) * 2021-04-16 2025-04-02 Nippon Shokubai Co., Ltd. Agent anti-coronavirus
PT117220B (pt) 2021-05-11 2024-07-16 Inst Superior Tecnico Solução desinfetante compreendendo álcool e quitosano, processo para a sua obtenção e respetivos usos
JPWO2024135675A1 (fr) * 2022-12-22 2024-06-27

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3404987A (en) * 1965-03-31 1968-10-08 Procter & Gamble Food preservative compositions and method for inhibiting microbial growth in food products
LU77562A1 (de) * 1977-06-17 1979-03-26 Ciba Geigy Ag Verfahren zur herstellung von neuen pharmazeutischen praeparaten
EP0012115A1 (fr) 1978-12-04 1980-06-11 Ciba-Geigy Ag Préparations pharmaceutiques pour le traitement topique d'infections virales
US4503070A (en) * 1981-07-31 1985-03-05 Eby Iii George A Method for reducing the duration of the common cold
US4956385A (en) * 1981-07-31 1990-09-11 Eby Iii George A Method for reducing the duration of the common cold
AU553789B2 (en) * 1982-06-30 1986-07-24 Biorex Laboratories Ltd. Glycyrrhetinic acid derivatives in cream compositions
US4661354A (en) * 1984-06-21 1987-04-28 Finnerty Edmund F Topical treatment of herpes simplex with a zinc sulfate-camphor water solution
EP0285357A3 (fr) * 1987-03-31 1989-10-25 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Lutte contre les rétrovirus
JP3095488B2 (ja) * 1991-10-30 2000-10-03 株式会社資生堂 噴霧用ゲル基剤およびそれを用いた噴霧用点鼻剤
GB9202464D0 (en) * 1992-02-05 1992-03-18 Danbiosyst Uk Composition for nasal administration
EP0692253A4 (fr) 1992-08-07 1998-06-03 Nippon Soda Co Agent prophylactique pour la mastite des animaux domestiques
US6321750B1 (en) * 1993-05-03 2001-11-27 Patrick D. Kelly Condom lubricants with zinc salts as anti-viral additives
FR2715300B1 (fr) * 1994-01-24 1996-03-29 Aromafarm Ltd Solution injectable de fluorure de benzalkonium et application à titre d'antiviral ou d'anti-infectieux.
HRP950149A2 (en) 1994-04-13 1997-06-30 Janssen Pharmaceutica Nv Intranasal antimigrene composition
SE518597C2 (sv) * 1994-05-04 2002-10-29 Medicarb Ab Användning av kitosan i kombination med en sulfaterad, negativt laddad polysackarid för framställning av en dentalt verksam munhygienkomposition för behandling av parodontit, plaques och/eller karies
NL9500216A (nl) * 1995-02-06 1996-09-02 Bio Pharma Sciences Bv Farmaceutische samenstelling voor de behandeling van herpes.
JP3837769B2 (ja) 1995-06-12 2006-10-25 大塚製薬株式会社 抗ウイルス剤
GB9525083D0 (en) * 1995-12-07 1996-02-07 Danbiosyst Uk Vaccine compositions
US6344210B2 (en) * 1996-05-10 2002-02-05 Charles A. Fust Composition for freshening nostrils and sinus cavities
SE507028C2 (sv) * 1996-08-06 1998-03-16 Medicarb Ab Ny medicinsk användning
SE508760C2 (sv) 1997-04-29 1998-11-02 Medicarb Ab Användning av en komposition innefattande kitosan i kombination med en polysackarid, som aktiv komponent i ett lösningsmedel, för framställning av ett spendoppningsmedel för mjölkproducerande djur
TW546151B (en) * 1997-07-23 2003-08-11 Senju Pharma Co Aqueous liquid pharmaceutical composition containing as main component benzopyran derivative
GB9725084D0 (en) * 1997-11-28 1998-01-28 Medeva Europ Ltd Vaccine compositions
US20020022660A1 (en) * 1998-01-20 2002-02-21 Hanuman B. Jampani Deep penetrating antimicrobial compositions
DE19818842C1 (de) * 1998-04-28 2000-01-05 Suedzucker Ag Erkältungsmittel
US6080783A (en) * 1998-09-01 2000-06-27 Gum Tech International, Inc. Method and composition for delivering zinc to the nasal membrane
WO2000015192A1 (fr) 1998-09-17 2000-03-23 Zonagen, Inc. Procedes et substances pour gels contraceptifs bioadhesifs
US6231889B1 (en) * 1998-09-21 2001-05-15 Chronorx, Llc Unit dosage forms for the treatment of herpes simplex
US6428814B1 (en) * 1999-10-08 2002-08-06 Elan Pharma International Ltd. Bioadhesive nanoparticulate compositions having cationic surface stabilizers
US6423329B1 (en) * 1999-02-12 2002-07-23 The Procter & Gamble Company Skin sanitizing compositions
US20020151521A1 (en) * 1999-03-30 2002-10-17 Burke Peter A. Universal antiviral composition
US6570054B1 (en) * 1999-05-21 2003-05-27 The Procter & Gamble Company Absorbent article having a stable skin care composition
US20040033260A1 (en) * 1999-10-19 2004-02-19 The Procter & Gamble Company Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc
FR2801601B1 (fr) * 1999-11-26 2003-04-25 Rhodia Chimie Sa Complexe silicone reticulable thermiquement / adhesif dont l'interface possede une force de decollement modulable
US20030206958A1 (en) * 2000-12-22 2003-11-06 Cattaneo Maurizio V. Chitosan biopolymer for the topical delivery of active agents
JP2001271098A (ja) * 2000-03-24 2001-10-02 Lion Corp 電解洗浄水及びその製造方法、並びに、その電解洗浄水を用いる衣類又は食器の洗浄システム
US6638915B1 (en) * 2000-06-30 2003-10-28 Harold Killam Anti-viral composition
US20020136768A1 (en) * 2000-11-14 2002-09-26 Staats Victor J. Antimicrobial composition
CA2433037C (fr) * 2000-12-28 2010-12-21 Takeda Chemical Industries, Ltd. Preparation a liberation prolongee
EP1420642A2 (fr) * 2001-07-02 2004-05-26 Surecide Technologies, LLC Nouvelles compositions antimicrobiennes synergiques et procedes associes
JP2005514510A (ja) 2001-12-21 2005-05-19 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー キトサン−金属錯体を含有する抗菌性固体表面材料
WO2003066001A2 (fr) * 2002-02-07 2003-08-14 The Trustees Of Columbia University In The City Of New York Compositions de sels de zinc contre l'irritation des muqueuses dues a des spermicides et des microbicides
JP4603891B2 (ja) 2002-10-31 2010-12-22 パク，レ−オク 抗癌剤組成物
WO2004080210A1 (fr) 2003-03-14 2004-09-23 Boehringer Ingelheim Danmark A/S Compositions a base de metaux alimentaires destinees a soutenir le developpement physiologique des intestins et a prevenir la diarrhee
CN1267102C (zh) 2003-06-05 2006-08-02 广西半宙制药股份有限公司 一种具有抗病毒作用的复合物及其制备方法

Also Published As

Publication number Publication date
WO2005074947A2 (fr) 2005-08-18
BRPI0417559A (pt) 2007-03-27
DE602004018032D1 (de) 2009-01-08
US8470346B2 (en) 2013-06-25
US7968122B2 (en) 2011-06-28
IL176161A0 (en) 2006-10-05
EP1706122B1 (fr) 2008-11-26
US20110223259A1 (en) 2011-09-15
NO20063147L (no) 2006-09-08
JP2007513959A (ja) 2007-05-31
EP1706122A2 (fr) 2006-10-04
ATE415166T1 (de) 2008-12-15
WO2005074947A3 (fr) 2005-09-22
KR20060118573A (ko) 2006-11-23
DK1706122T3 (da) 2009-03-23
US20050232895A1 (en) 2005-10-20
EA200601124A1 (ru) 2006-12-29
CA2549083A1 (fr) 2005-08-18
AU2004315262A1 (en) 2005-08-18
MXPA06006650A (es) 2007-01-26

Similar Documents

Publication Publication Date Title
MA28334A1 (fr) Compositions pharmaceutiques antivirales
NO20074807L (no) Fast farmasoytisk doseringsformulering
CY1112687T1 (el) Μεθοδος για χρηση δικετοπιπεραζινων και συνθεσεις που περιλαμβανουν αυτες
NO20005224D0 (no) BTK inhibitorer og fremgangsmÕter for deres identifikasjon og anvendelse
WO2006007448A3 (fr) Compositions pharmaceutiques de co-cristal et methodes d'utilisation associees
WO2004064769A3 (fr) Methodes de production et d'utilisation d'agents d'administration topique
WO2007010034A3 (fr) Copolymere ampholyte, sa production et son utilisation
ATE289640T1 (de) Amidofunktionelle aminopolydiorganosiloxane
DK2128246T3 (da) Fremgangsmåder og sammensætninger til fremstilling af ortogonale tRNA-aminoacyl-tRNA-syntetasepar.
TW200420573A (en) Bifunctional heterocyclic compounds and methods of making and using same
DK1355889T3 (da) Substituerede triazoldiaminderivater som kinaseinhibitorer
NO20052306D0 (no) Dispergerbare farmasoytiske blandinger.
NO20044898L (no) Nye etonogestrel estere
WO2007076174A3 (fr) Procédés, systèmes et dispositif pour marqueurs multidomaines
ITRM20020529A1 (it) Polimeri sterilizzanti, processo di loro preparazione ed uso.
AP2005003451A0 (en) HIV integrase inhibitors.
DK1220852T3 (da) Substituerede diazepaner
EA200601596A1 (ru) Улучшенный состав 6-меркаптопурина
DE60209359D1 (de) Lösungsmittelverklebungsverfahren
PT1355906E (pt) Derivados de 2h-1-benzopirano processos para a sua preparacao e as suas composicoes farmaceuticas
WO2006098998A3 (fr) Procedes et compositions de modulation de l'integrite vasculaire
FI20031191A7 (fi) Monoamiinin takaisinoton estäjä
ATE397973T1 (de) Mischung, umfassend ein tensid und ein cotensid
NO20052478D0 (no) Vitamin D-analoger, sammensetninger omfattende analogene og deres anvendelse.
DK1713438T3 (da) Medicinsk sæbe